Senti Biosciences
South San Francisco, USA
|
Senti Biosciences is a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases. The company's product SENTI-202 is a potential first-in-class, off-the-shelf Logic Gated CAR-NK investigational cell therapy for the treatment of acute myeloid leukemia (“AML”).